Zafirlukast

FDA Approved: * November 18, 2010
Pharm Company: * DR REDDYS LABS LTD
Category: Asthma

Zafirlukast is an orally administered leukotriene receptor antagonist (LTRA) used for the chronic treatment of asthma. While zafirlukast is generally well tolerated, headache and stomach upset often occur. Some rare side effects can occur, which can be life-threatening, such as liver failure. Churg-Strauss syndrome has been associated with zafirlukast, but the relationship isn't thought to be causative in nature. Overdoses of zafirlukast tend to be self-limiting. Zafirlukast, like other LTRAs... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Zafirlukast ACCOLATE10
Zafirlukast 10 mg Oral Tablet
NDC: 49884-303
Labeler:
Par Pharmaceutical Inc.
Zafirlukast ACCOLATE20
Zafirlukast 20 mg Oral Tablet
NDC: 49884-304
Labeler:
Par Pharmaceutical Inc.
Zafirlukast R;625
Zafirlukast 10 mg Oral Tablet
NDC: 55111-625
Labeler:
Dr. Reddys Laboratories Limited
Zafirlukast R;626
Zafirlukast 20 mg Oral Tablet
NDC: 55111-626
Labeler:
Dr. Reddys Laboratories Limited
Zafirlukast R;626
Zafirlukast 20 mg Oral Tablet
NDC: 68084-059
Labeler:
American Health Packaging
Zafirlukast ACCOLATE10
Zafirlukast 10 mg Oral Tablet
NDC: 0310-0411
Labeler:
Astrazeneca Pharmaceuticals Lp
Zafirlukast ACCOLATE20
Zafirlukast 20 mg Oral Tablet
NDC: 0310-0412
Labeler:
Astrazeneca Pharmaceuticals Lp
Zafirlukast R;626
Zafirlukast 20 mg Oral Tablet, Film Coated
NDC: 50268-805
Labeler:
Avpak
Zafirlukast R;626
Zafirlukast 20 mg Oral Tablet, Film Coated
NDC: 68151-1977
Labeler:
Carilion Materials Management
Zafirlukast 20 mg Oral Tablet, Coated
NDC: 0904-6646
Labeler:
Major Pharmaceuticals
More Results

Related Brands

Drugs with the same active ingredients